Literature DB >> 19641489

Public health consequences of chronic kidney disease.

D E Weiner1.   

Abstract

With its rising incidence and prevalence, chronic kidney disease (CKD) is a major public health concern, both in the United States and worldwide. Recent worldwide initiatives have attempted to garner attention for CKD by emphasizing that the condition is "common, harmful, and treatable." In the United States, as many as 26 million adults may have CKD, an increase from approximately 10% of the US adult population between 1988 and 1994 to >13% just one decade later. Similar rates have been seen worldwide, with a CKD prevalence of 13% in Beijing, China and 16% in Australia. In the United States, the dramatic rise in the prevalence of CKD likely reflects similar increases in obesity and its sequelae-namely, diabetes, hypertension, and cardiovascular disease. The prevalence of CKD, as well as its associated costs, is expected to continue to increase.

Entities:  

Mesh:

Year:  2009        PMID: 19641489      PMCID: PMC2788514          DOI: 10.1038/clpt.2009.137

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

1.  Cardiovascular disease and chronic renal disease: a new paradigm.

Authors:  M J Sarnak; A S Levey
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

Review 2.  Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Authors:  Giovanni F M Strippoli; Sankar D Navaneethan; David W Johnson; Vlado Perkovic; Fabio Pellegrini; Antonio Nicolucci; Jonathan C Craig
Journal:  BMJ       Date:  2008-02-25

3.  United States Renal Data System 2008 Annual Data Report.

Authors:  Allan J Collins; Robert N Foley; Charles Herzog; Blanche Chavers; David Gilbertson; Areef Ishani; Bertram Kasiske; Jiannong Liu; Lih-Wen Mau; Marshall McBean; Anne Murray; Wendy St Peter; Haifeng Guo; Qi Li; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2009-01       Impact factor: 8.860

4.  Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Authors:  T H Jafar; C H Schmid; M Landa; I Giatras; R Toto; G Remuzzi; G Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; S Shahinfar; P E de Jong; D de Zeeuw; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

5.  Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.

Authors:  Andrew S Levey; Anton C Schoolwerth; Nilka Ríos Burrows; Desmond E Williams; Karma Rabon Stith; William McClellan
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

6.  Population-based screening for CKD.

Authors:  Neil R Powe; L Ebony Boulware
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

7.  Prevalence and factors associated with CKD: a population study from Beijing.

Authors:  LuXia Zhang; PuHong Zhang; Fang Wang; Li Zuo; Ying Zhou; Ying Shi; Gang Li; ShuFang Jiao; ZeJun Liu; WanNian Liang; HaiYan Wang
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

8.  State-specific prevalence of obesity among adults--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-07-18       Impact factor: 17.586

9.  State-specific incidence of diabetes among adults--participating states, 1995-1997 and 2005-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-10-31       Impact factor: 17.586

10.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

View more
  27 in total

1.  Trends in estimated kidney function: the FINRISK surveys.

Authors:  Auni Juutilainen; Helena Kastarinen; Riitta Antikainen; Markku Peltonen; Veikko Salomaa; Jaakko Tuomilehto; Pekka Jousilahti; Jouko Sundvall; Tiina Laatikainen; Mika Kastarinen
Journal:  Eur J Epidemiol       Date:  2012-04       Impact factor: 8.082

Review 2.  Renal stem cell reprogramming: Prospects in regenerative medicine.

Authors:  Elvin E Morales; Rebecca A Wingert
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

3.  Estimating individual glomerular volume in the human kidney: clinical perspectives.

Authors:  Victor G Puelles; Monika A Zimanyi; Terence Samuel; Michael D Hughson; Rebecca N Douglas-Denton; John F Bertram; James A Armitage
Journal:  Nephrol Dial Transplant       Date:  2011-10-09       Impact factor: 5.992

4.  A web-based training program to support chronic kidney disease screening by community pharmacists.

Authors:  Pankti A Gheewala; Gregory M Peterson; Syed Tabish R Zaidi; Luke Bereznicki; Matthew D Jose; Ronald L Castelino
Journal:  Int J Clin Pharm       Date:  2016-06-21

Review 5.  Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions.

Authors:  Ritu K Soni; Anna C Porter; James P Lash; Mark L Unruh
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

6.  Warfarin dosing in patients with impaired kidney function.

Authors:  Nita A Limdi; Mohit A Limdi; Larisa Cavallari; Aaron M Anderson; Michael R Crowley; Melissa F Baird; Michael Allon; T Mark Beasley
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

7.  Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy.

Authors:  Ke Yang; Cheng Wang; Ling Nie; Xiaohui Zhao; Jun Gu; Xu Guan; Song Wang; Tangli Xiao; Xinli Xu; Ting He; Xuefeng Xia; Junping Wang; Jinghong Zhao
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

8.  Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease.

Authors:  Natasha J McIntyre; Richard Fluck; Chris McIntyre; Maarten Taal
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

9.  First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.

Authors:  Michael L Granda; Frederick A Schroeder; Ronald H J Borra; Nathan Schauer; Ehimen Aisaborhale; Alexander R Guimaraes; Jacob M Hooker
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07

10.  Risk factors for ESRD: lessons from a community study and implications for public health.

Authors:  Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2010-01       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.